Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Papillomavirus Infections × Lacteol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 1 Solid Tumor, Adult 1 Papillomavirus Infections 1 Dysbiosis 1 Colorectal Neoplasms 1 Candidiasis, Oral 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 34 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 27 Papillomavirus Vaccines 22 Vaccines 11 Human Papillomavirus Recombinant Vaccine nonavalent 10 Radiotherapy, Intensity-Modulated 7 Human Papillomavirus DNA Tests 7 Colposcopy 7 Cisplatin 7 Carboplatin 6 Vaccines, Synthetic 5 Specimen Handling 5 Educational Status 5 Blood Specimen Collection 5 Vaginal Smears 4 Engerix-B 4 Early Intervention, Educational 4 fludarabine 3 artesunic acid 3 artemisinin 3 Watchful Waiting 3 Surveys and Questionnaires 3 Paclitaxel 3 Methods 3 Imiquimod 3 Hepatitis A Vaccines 3 Cyclophosphamide 3 halofantrine 2 fludarabine phosphate 2 epigallocatechin gallate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06467942 2024-06-21

ELIMVLHPV

Peking University People's Hospital

Phase NA Recruiting

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡